Works matching IS 15228517 AND DT 2014 AND VI 16 AND IP suppl_2

Results: 436

P17.46 LATE PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS: COMPARABLE ANALYSIS WITH REAL TUMOR PROGRESSION.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii98, doi. 10.1093/neuonc/nou174.375

By:

Kamer, S.;
Akagunduz, O.;
Ertan, Y.;
Akalın, T.;
Özgiray, E.;
Oner, K.;
Eraslan, C.;
Çallı, C.;
Oktar, N.;
Anacak, Y.

Publication type:

Article

P04.09 THE PROGNOSTIC POTENTIAL OF CD133 AND NESTIN IN A POPULATION-BASED COHORT OF GLIOMA PATIENTS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii38, doi. 10.1093/neuonc/nou174.141

By:

Dahlrot, R.H.;
Hansen, S.;
Schroeder, H.D.;
Jensen, S.S.;
Hjelmborg, J.;
Kristensen, B.W.

Publication type:

Article

O5.04 PRELIMINARY RESULTS OF THE GALA-5 STUDY: AN EVALUATION OF THE TOLERABILITY AND FEASIBILITY OF COMBINING 5-AMINO-LEVULINIC ACID (5-ALA) WITH CARMUSTINE WAFERS (GLIADEL) IN THE SURGICAL MANAGEMENT OF PRIMARY GLIOBLASTOMA.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii10

By:

Watts, C.;
Wanek, K.;
Smith, P.;
Counsell, N.

Publication type:

Article

P15.17 PSYCHOSOCIAL SUPPORT BY MEDICAL SOCIAL WORKER IS BENEFICIAL FOR PATIENTS WITH MALIGN BRAIN TUMORS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii77, doi. 10.1093/neuonc/nou174.296

By:

Gröntoft, M.;
Westermark, M.;
Hylin, S.;
Stragliotto, G.

Publication type:

Article

O6.03 A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE «DEND/GBM» TRIAL.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii12, doi. 10.1093/neuonc/nou174.44

By:

Gállego Pérez-Larraya, J.;
Tejada-Solís, S.;
de Cerio, A.L.;
Inogés, S.;
Espinós, J.;
Díez-Valle, R.

Publication type:

Article

P18.02 A COMPARISON OF THE EFFECTS OF ATTENTION DEFICIT ON REHABILITATION FUNCTIONAL OUTCOMES IN BRAIN TUMOR PATIENTS AND SUBACUTE STROKE PATIENTS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii110, doi. 10.1093/neuonc/nou174.426

By:

Young, H. Eun;
Im, S.

Publication type:

Article

P04.06 TERT PROMOTER MUTATIONS CONTRIBUTE TO SUBSET PROGNOSTICATION OF LOWER GRADE GLIOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii37, doi. 10.1093/neuonc/nou174.138

By:

Chan, A.K.;
Yao, Y.;
Zhang, Z.;
Chung, N.Y.;
Li, K.K.;
Chan, D.T.;
Poon, W.S.;
Zhou, L.;
Ng, H.K.

Publication type:

Article

P18.09 STRESS INDUCED IMMUNE DYSFUNCTION IN NEURO-ONCOLOGY CAREGIVERS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii112, doi. 10.1093/neuonc/nou174.433

By:

Sherwood, P.R.;
Weimer, J.;
Price, T.;
Ren, D.;
Lieberman, F.;
Donovan, H.

Publication type:

Article

O9.03 BRAIN TUMORS IN SWEDEN: DATA FROM A POPULATION BASED REGISTRY 1999-2012.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii20, doi. 10.1093/neuonc/nou174.74

By:

Asklund, T.;
Malmström, A.;
Bergqvist, M.;
Björ, O.;
Henriksson, R.

Publication type:

Article

P18.04 CLINICAL PROGRESS AND SURVIVAL OF PATIENTS WITH GLIOBLASTOMA AFTER HYPO-FRACTIONATED RADIOTHERAPY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii111, doi. 10.1093/neuonc/nou174.428

By:

Jakes, A.D.;
Boyer, M.;
Hatfield, P.

Publication type:

Article

P17.47 COMPREHENSIVE PROTEOMIC PROFILING OF BEVACIZUMAB-RESISTANT GLIOBLASTOMA MULTIFORME.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii98, doi. 10.1093/neuonc/nou174.376

By:

Kaufman, K.L.;
Ly, L.;
McKay, M.;
Mallawaaratchy, D.M.;
Mactier, S.;
Crossett, B.;
Molloy, M.;
Buckland, M.E.;
McDonald, K.L.;
Christopherson, R.I.

Publication type:

Article

O8.03 LOW GRADE DIFFUSE ASTROCYTOMA - PROGNOSTIC FACTORS TO ANAPLASTIC TRANSFORMATION.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii18, doi. 10.1093/neuonc/nou174.64

By:

Izquierdo, C.;
Majos, C.;
Simó, M.;
Lucas, A.;
Macià, M.;
Plans, G.;
Gil, M.;
Velasco, R.;
Bruna, J.

Publication type:

Article

P17.71 ROLE OF ATRX AND TERT EXPRESSION AS DIAGNOSTIC AND PROGNOSTIC FACTORS ON ANAPLASTIC GLIOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii104, doi. 10.1093/neuonc/nou174.400

By:

Patanè, M.;
Calatozzolo, C.;
Mazzetti, S.;
Nunziata, R.;
Spinello, S.;
Farinotti, M.;
Finocchiaro, G.;
Pollo, B.

Publication type:

Article

O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii23, doi. 10.1093/neuonc/nou174.83

By:

Figarella-Branger, D.;
Mokhtari, K.;
Dehais, C.;
Jouvet, A.;
Uro-Coste, E.;
Colin, C.;
Carpentier, C.;
Ducray, F.;
Idbaih, A.;
Network, French POLA

Publication type:

Article

P15.06 QUALITY OF PATIENTS LIFE WITH METASTATIC TUMORS OF THE SPINE AND SPINAL CORD.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii75, doi. 10.1093/neuonc/nou174.285

By:

Gazieva, S.G.;
Tolibova, N.;
Niyozova, S.;
Prokhorova, A.

Publication type:

Article

P17.50 PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii99, doi. 10.1093/neuonc/nou174.379

By:

Kumthekar, P.;
Grimm, S.A.;
Marymont, M.;
Mehta, M.;
Chandler, J.;
Muro, K.;
Jovanovic, B.;
Helenowski, I.;
McCarthy, K.;
Raizer, J.

Publication type:

Article

P10.01 PARANEOPLASTIC BRAINSTEM ENCEPHALITIS AS PRESENTING SYMPTOM OF MERKEL CELL CARCINOMA (MCC) FOLLOWED BY INTRACRANIAL AND LEPTOMENINGEAL DIFFUSION.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii58, doi. 10.1093/neuonc/nou174.221

By:

Ferrandi, D.;
Prevost, C.;
Mascolo, M.;
Bottaro, R.;
Melato, M.;
Palermo, M.;
Varese, P.;
Traverso, E.;
Ruiz, L.

Publication type:

Article

O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii14, doi. 10.1093/neuonc/nou174.49

By:

Labussiere, M.;
Boisselier, B.;
Mokhtari, K.;
Di Stefano, A.;
Rahimian, A.;
Saulnier, O.;
Paterra, R.;
Finocchiaro, G.;
Marie, Y.;
Sanson, M.

Publication type:

Article

P10.03 OPSOCLONUS MYOCLONUS SYNDROME ASSOCIATED WITH LUNG ADENOCARCINOMA.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii58, doi. 10.1093/neuonc/nou174.223

By:

Matas, A.F.M.R.;
Veiga, A.S.B.T.;
Gabriel, J.P.M.S.;
Silva, M.R.

Publication type:

Article

P17.55 UNRAVELLING GRADE 3 GLIOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii100, doi. 10.1093/neuonc/nou174.384

By:

Mathew, R.;
Goacher, E.;
Bhargava, D.;
Chakrabarty, A.;
Roberts, P.;
Goodden, J.;
Loughrey, C.;
Chumas, P.

Publication type:

Article

P01.06 HIF-1 AND HIF-2 AS POSIBLE NEW TARGETS IN THE TREATMENT OF VON HIPPEL-LINDAU DISEASE HEMANGIOBLASTOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii27, doi. 10.1093/neuonc/nou174.99

By:

Viñas, D.;
Serrano-Heras, G.;
Perona-Morata, A.B.;
De Andres, P.;
Fortes, J.;
Segura, T.;
De Campos, J.M.

Publication type:

Article

O9.10 ANTI-EPILEPTIC TREATMENT IN GLIOMA, A NORWEGIAN POPULATION-BASED STUDY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii22, doi. 10.1093/neuonc/nou174.81

By:

Knudsen-Baas, K.M.;
Johannesen, T.B.;
Engeland, A.;
Engelsen, B.A.;
Storstein, A.M.;
Owe, J.F.

Publication type:

Article

P17.91 CLINICAL VARIABLES SERVE AS PREDICTIVE FACTORS IN A MODEL FOR CLINICAL RESPONSE TO BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME: AN OBSERVATIONAL STUDY OF A COHORT OF CONSECUTIVE NON-SELECTED PATIENTS FROM A SINGLE INSTITUTION.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii109, doi. 10.1093/neuonc/nou174.420

By:

Urup, T.;
Grunnet, K.;
Christensen, I.J.;
Michaelsen, S.R.;
Broholm, H.;
Stockhausen, M.T.;
Lassen, U.;
Poulsen, H.S.

Publication type:

Article

P16.07 BEVACIZUMAB AS PALLIATIVE TREATMENT OF FAMILIAL SCHWANNOMATOSIS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii79, doi. 10.1093/neuonc/nou174.304

By:

Clement, P.M.;
Blockmans, D.;
Bechter, O.E.;
Van Calenbergh, F.;
Legius, E.

Publication type:

Article

P13.04 A STUDY ON DOSIMETRIC PERFORMANCE OF 5 MM MLCS FOR VMAT BASED STEREOTACTIC RADIOSURGERY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii66, doi. 10.1093/neuonc/nou174.250

By:

Robinson, M.;
Padmanaban, S.;
Van den Heuvel, F.;
Blesing, C.

Publication type:

Article

P17.62 THE IMPORTANCE OF DELAYED PSEUDOPROGRESSION AND THE PROBLEM WITH RANO IN GBM.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii101, doi. 10.1093/neuonc/nou174.391

By:

Neuwelt, E.A.;
Muldoon, L.L.;
Gahramanov, S.

Publication type:

Article

O4.02 EXOSOMAL MIRNA FROM GLIOMA-ASSOCIATED MESENCHYMAL STEM CELLS PROMOTE GLIOMA GROWTH AND PROGRESSION.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii7, doi. 10.1093/neuonc/nou174.23

By:

Figueroa, J.M.;
Shahar, T.;
Hossain, A.;
Gumin, J.;
Lang, F.

Publication type:

Article

P11.07 BLOOD-BRAIN BARRIER DISRUPTION AND INTRA-ARTERIAL METHOTREXATE-BASED THERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: A SINGLE-INSTITUTION EXPERIENCE.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii60, doi. 10.1093/neuonc/nou174.230

By:

Kobyakov, G.L.;
Aronov, M.S.;
Lubnin, A.Y.;
Yakovlev, S.B.;
Serova, N.K.;
Tropinskaya, O.F.;
Shishkina, L.V.;
Ryzhova, M.V.;
Poddubsky, A.A.;
Inozemtceva, M.V.

Publication type:

Article

P17.29 IDENTIFICATION OF NOVEL MOLECULAR TARGETS FOR TEMOZOLOMIDE-BASED THERAPIES AGAINST GLIOBLASTOMA: A COMPREHENSIVE SHRNA-BASED SCREEN OF DNA REPAIR FACTORS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii93, doi. 10.1093/neuonc/nou174.358

By:

Erasimus, H.;
Fritah, S.;
Haan, S.;
Niclou, S.P.;
Van Dyck, E.

Publication type:

Article

P01.18 AUTOCRINE VEGFC-VEGFR2 SIGNALING IS OF IMPORTANCE FOR THE GROWTH OF GLIOBLASTOMA MULTIFORME.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii31, doi. 10.1093/neuonc/nou174.111

By:

Michaelsen, S.R.;
Nedergaard, M.K.;
Villingshøj, M.;
Pedersen, P.;
Stockhausen, M.;
Poulsen, H.S.

Publication type:

Article

O5.09 VENTRICULAR HIGH GRADE GLIOMA: NEUROENDOSCOPY AND ADJUVANT THERAPY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii11, doi. 10.1093/neuonc/nou174.40

By:

Oppido, P.A.;
Cattani, F.;
Carapella, C.M.;
Villani, V.

Publication type:

Article

O1.07 INTRACRANIAL HEMANGIOPERICYTOMAS LACK TYPICAL CYTOGENETIC AND EPIGENETIC FEATURES OF MENINGIOMAS: A COMPREHENSIVE MOLECULAR GENETIC STUDY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii2, doi. 10.1093/neuonc/nou174.7

By:

Kraemer, D.;
Orie, S.I.;
Ketter, R.;
Oertel, J.;
Urbschat, S.

Publication type:

Article

P17.75 UTILITY OF 3D SURGICAL PLANNING FOR RESECTION OF HIGH-GRADE GLIOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii105, doi. 10.1093/neuonc/nou174.404

By:

Rozumenko, A.V.;
Rozumenko, V.D.

Publication type:

Article

P16.26 MINIMUM APPARENT DIFFUSION COEFFICIENT MEASUREDBY 3T MR IMAGES IN GLIOBLASTOMA AND O6-METHYLGUANINE-DNA-METHYTRANSFERASE GENE PROMOTER METHYLATED STATUS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii84, doi. 10.1093/neuonc/nou174.321

By:

Asteggiano, F.;
Vella, A.;
Scola, E.;
Pirola, E.;
Minichiello, M.;
Miozzo, M.;
Caroli, M.;
Bergamasco, L.;
Rampini, P.;
Triulzi, F.

Publication type:

Article

P16.10 DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii80, doi. 10.1093/neuonc/nou174.306

By:

Galldiks, N.;
Dunkl, V.;
Stoffels, G.;
Hutterer, M.;
Rapp, M.;
Kebir, S.;
Goldbrunner, R.;
Ruge, M.I.;
Schmidt, M.;
Langen, K.

Publication type:

Article

P05.03 EFFECT OF COMBINED THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE (TMZ) IN PEDIATRIC MALIGNANT GLIOMAS (MG).

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii43, doi. 10.1093/neuonc/nou174.161

By:

Geludkova, O.G.;
Borodina, I.D.;
Melikian, A.G.;
Kushel, Y.V.;
Shishkina, L.V.;
Rizhova, M.V.;
Gorbatih, S.V.;
Popov, V.E.;
Pavlova, E.V.;
Scherbenko, O.I.

Publication type:

Article

P18.08 A MULTICENTRIC, OBSERVATIONAL, NON INTERVENTIONAL STUDY OF EFFICACY AND SAFETY OF LACOSAMIDE FOR THE TREATMENT OF EPILEPTIC SEIZURES IN PATIENTS WITH BRAIN TUMORS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii112, doi. 10.1093/neuonc/nou174.432

By:

Pardo-Moreno, J.;
Sepúlveda, J.;
Conde-Moreno, A.;
Barón, M.;
Reynes, G.;
Belenguer, A.

Publication type:

Article

P04.13 EXPRESSION OF PLURIPOTENCY STEMNESS GENES IN HUMAN GLIOMAS OF DIFFERENT TUMOR GRADES BEFORE AND AFTER CHEMOTHERAPY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii39, doi. 10.1093/neuonc/nou174.145

By:

Dreher, L.;
Röhn, G.;
Perrech, M.;
Goldbrunner, R.;
Timmer, M.

Publication type:

Article

O4.03 GLIOBLASTOMA STIMULATED ANGIOGENESIS IS MEDIATED BY MMP-3 ACTIVATED MMP-1 VIA BRAIN ENDOTHELIAL CELL ASSOCIATED PROTEASE ACTIVATED RECEPTOR 1 (PAR1) AND IS ENHANCED UNDER HYPOXIC CONDITIONS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii7, doi. 10.1093/neuonc/nou174.24

By:

Briggs, S.;
Stephenson, K.;
Holliday, J.;
Peckham, R.;
Arthur, D.;
Papanikolaou, M.;
Butt, A.;
Pickford, A.;
Pilkington, G.;
Fillmore, H.L.

Publication type:

Article

O5.01 STANDARDS AND ADVANCED TESTING FOR INTRAOPERATIVE LANGUAGE AND COGNITIVE MAPPING.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii9, doi. 10.1093/neuonc/nou174.32

By:

Comi, A.;
Riva, M.;
Casarotti, A.;
Fava, E.;
Pessina, F.;
Papagno, C.;
Bello, L.

Publication type:

Article

P16.19 THE EFFECTS OF BEVACIZUMAB ON MR-IMAGING AND 1H-MR-SPECTROSCOPY (MRS) IN PATIENTS WITH HIGH GRADE GLIOMAS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii82, doi. 10.1093/neuonc/nou174.315

By:

Knecht, U.;
Slotboom, J.;
Ochsenbein, A.;
Beck, J.;
Pica, A.;
Wiest, R.

Publication type:

Article

P16.06 EARLY PERFUSION CHANGES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH BEVACIZUMAB: PRELIMINARY EVALUATION BY THE PARAMETRIC RESPONSE MAP DERIVED FROM DYNAMIC CONTRAST-ENHANCED MRI.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii79, doi. 10.1093/neuonc/nou174.303

By:

Vidiri, A.;
Marzi, S.;
Piludu, F.;
Villani, V.;
Antenucci, A.;
Terrenato, I.;
Fabi, A.;
Pace, A.;
Carapella, C.M.

Publication type:

Article

O7.03 IDH-1 MUTATED GLIOBLASTOMAS HAVE A LESS INVASIVE PHENOTYPE THAN IDH-1 WILD TYPE GLIOBLASTOMAS: A DIFFUSION TENSOR IMAGING STUDY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii15, doi. 10.1093/neuonc/nou174.54

By:

Price, S.J.;
Boonzaier, N.R.;
Lupson, V.;
Larkin, T.

Publication type:

Article

O3.03 THE SPECTRUM OF LATE PAROXYSMAL NEUROLOGICAL SYNDROMES AFTER BRAIN IRRADIATION.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii5, doi. 10.1093/neuonc/nou174.17

By:

Berzero, G.;
Group, Pavia Neuro-oncology;
Ducray, F.;
Giometto, B.;
Silvani, A.;
Salmaggi, A.;
Eoli, M.;
Finocchiaro, G.;
Vidiri, A.;
Pace, A.

Publication type:

Article

P13.02 PROTON THERAPY FOR BRAIN AND SKULL BASE TUMORS AT THE NEW OPENING TRENTO FACILITY.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii65, doi. 10.1093/neuonc/nou174.248

By:

Amelio, D.;
Cianchetti, M.;
Rombi, B.;
Vennarini, S.;
Dionisi, F.;
Vinante, L.;
Amichetti, M.

Publication type:

Article

P08.27 LEPTOMENINGEAL METASTASES: A RANO PROPOSAL FOR RESPONSE CRITERIA.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii56, doi. 10.1093/neuonc/nou174.215

By:

Chamberlain, M.;
Junck, L.;
Brandsma, D.;
Soffietti, R.;
Rudà, R.;
Raizer, J.;
Boogerd, W.;
Taillibert, S.;
Groves, M.D.;
Le Rhun, E.

Publication type:

Article

P18.01 COMPLEMENTARY THERAPY USE IN A COHORT OF SWISS GLIOMA PATIENTS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii110, doi. 10.1093/neuonc/nou174.425

By:

Eisele, G.;
Roelcke, U.;
Conen, K.;
Huber, F.;
Weiss, T.;
Hofer, S.;
Heese, O.;
Westphal, M.;
Weller, M.

Publication type:

Article

P11.08 CENTRAL NERVOUS SYSTEM LYMPHOMA IN A PATIENT WITH MYCOSIS FUNGOIDES.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii61, doi. 10.1093/neuonc/nou174.231

By:

Koeppen, S.;
Göricke, S.;
Rompoti, N.;
Sakarou, M.;
Keyvani, K.

Publication type:

Article

P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii91, doi. 10.1093/neuonc/nou174.350

By:

De Cock, L.;
Sala, Q.;
Barrie, M.;
Boucard, C.;
Metellus, P.;
Tabouret, E.;
Padovani, L.;
Figarella-Branger, D.;
Dufour, H.;
Chinot, O.

Publication type:

Article

P17.41 CLINICAL MANAGEMENT AND OUTCOME OF HISTOLOGICALLY VERIFIED ADULT BRAINSTEM GLIOMAS IN SWITZERLAND: A RETROSPECTIVE ANALYSIS OF 21 PATIENTS.

Published in:

Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii96, doi. 10.1093/neuonc/nou174.370

By:

Hundsberger, T.;
Tonder, M.;
Andreas, H.;
Brügge, D.;
Roelcke, U.;
Putora, P.M.;
Stupp, R.;
Weller, M.

Publication type:

Article